A detailed history of Apollon Wealth Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Apollon Wealth Management, LLC holds 4,102 shares of MRNA stock, worth $274,136. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,102
Previous 3,384 21.22%
Holding current value
$274,136
Previous $360,000 35.28%
% of portfolio
0.02%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$101.21 - $166.61 $72,668 - $119,625
718 Added 21.22%
4,102 $487,000
Q1 2024

May 02, 2024

BUY
$85.37 - $115.44 $43,880 - $59,336
514 Added 17.91%
3,384 $360,000
Q4 2023

Feb 06, 2024

SELL
$69.51 - $104.43 $235,499 - $353,808
-3,388 Reduced 54.14%
2,870 $285,000
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $437,412 - $574,429
4,537 Added 263.63%
6,258 $646,000
Q2 2023

Aug 04, 2023

SELL
$118.5 - $160.53 $68,493 - $92,786
-578 Reduced 25.14%
1,721 $209,000
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $123,721 - $179,682
-912 Reduced 28.4%
2,299 $353,000
Q4 2022

Feb 15, 2023

BUY
$118.38 - $210.04 $98,728 - $175,173
834 Added 35.09%
3,211 $576,000
Q3 2022

Nov 08, 2022

SELL
$118.07 - $194.18 $65,883 - $108,352
-558 Reduced 19.01%
2,377 $281,000
Q2 2022

Aug 11, 2022

SELL
$117.13 - $176.59 $50,483 - $76,110
-431 Reduced 12.8%
2,935 $419,000
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $282,764 - $525,571
-2,236 Reduced 39.91%
3,366 $580,000
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $945,959 - $1.54 Million
4,189 Added 296.46%
5,602 $1.36 Million
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $50,593 - $110,459
228 Added 19.24%
1,413 $544,000
Q2 2021

Aug 12, 2021

BUY
$129.91 - $234.98 $153,943 - $278,451
1,185 New
1,185 $278,000
Q3 2020

Nov 03, 2020

SELL
$54.34 - $94.85 $34,668 - $60,514
-638 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$29.67 - $80.0 $18,929 - $51,040
638 New
638 $41,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $26.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Apollon Wealth Management, LLC Portfolio

Follow Apollon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Wealth Management, LLC with notifications on news.